Grant: Doctoral Research Award: Canada Graduate Scholarships
McMaster University
$105,000.00
Characterizing the Role of Profibrotic Monocytes/Macrophages in the Progression of Fibrotic Lung Disease
EF 2019-20
Résumé
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown cause that involves scarring of the lung. IPF patients normally die relatively shortly after diagnosis, and there are limited options for treatment. We do not know how to predict the timing of death of patients with IPF, and we have a poor understanding of what causes the progression of this disease. However, white blood cells in the circulation called monocytes have been correlated with progression. Monocytes originate in the bone marrow, and then enter the circulation from which they can be recruited into various tissue types in the body. It is believed that these monocytes enter the lung, transition into macrophages, and begin to cause fibrosis. Quantity of monocytes has previously been positively correlated with poor outcomes in IPF, suggesting that these cells may play a causal role in the development of fibrotic lung disease. Therefore, it makes sense to study these cells and their properties to potentially gain a better understanding of what causes progression of IPF.
Here, we hypothesize that monocytes isolated from the blood of IPF patients are profibrotic and associated with progression of IPF. We also hypothesize that these monocytes enter the lung and contribute to fibrosis. To test this, we will collect blood from IPF patients and isolate monocytes. From there, we will examine the properties of these cells to identify "targets." We will then look for these targets in lung biopsies from patients with IPF to confirm that they are present in the lung. After determining viable targets present in both the blood and lungs of IPF patients, we will employ screening techniques to select an appropriate mouse model for studying these targets and their functions further. The results of this study may provide insight into better understanding what causes development of IPF, and potential routes for therapies for the disease.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
416720
Name
Vierhout Megan J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Characterizing the Role of Profibrotic Monocytes/Macrophages in the Progression of Fibrotic Lung Disease
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alternatively Activated Macrophages; Bioinformatics; Circulating Monocytes; Disease Progression; Idiopathic Pulmonary Fibrosis; Rna Sequencing; Surgical Lung Biopsy; Target Identification; Tissue Microarray; Transcriptomic Analysis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown cause that involves scarring of the lung. IPF patients normally die relatively shortly after diagnosis, and there are limited options for treatment. We do not know how to predict the timing of death of patients with IPF, and we have a poor understanding of what causes the progression of this disease. However, white blood cells in the circulation called monocytes have been correlated with progression. Monocytes originate in the bone marrow, and then enter the circulation from which they can be recruited into various tissue types in the body. It is believed that these monocytes enter the lung, transition into macrophages, and begin to cause fibrosis. Quantity of monocytes has previously been positively correlated with poor outcomes in IPF, suggesting that these cells may play a causal role in the development of fibrotic lung disease. Therefore, it makes sense to study these cells and their properties to potentially gain a better understanding of what causes progression of IPF.
Here, we hypothesize that monocytes isolated from the blood of IPF patients are profibrotic and associated with progression of IPF. We also hypothesize that these monocytes enter the lung and contribute to fibrosis. To test this, we will collect blood from IPF patients and isolate monocytes. From there, we will examine the properties of these cells to identify "targets." We will then look for these targets in lung biopsies from patients with IPF to confirm that they are present in the lung. After determining viable targets present in both the blood and lungs of IPF patients, we will employ screening techniques to select an appropriate mouse model for studying these targets and their functions further. The results of this study may provide insight into better understanding what causes development of IPF, and potential routes for therapies for the disease.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vierhout, Megan J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~